Invention Grant
- Patent Title: P2X7R antagonists and their use
- Patent Title (中): P2X7R拮抗剂及其用途
-
Application No.: US13035614Application Date: 2011-02-25
-
Publication No.: US08268861B2Publication Date: 2012-09-18
- Inventor: Michael C Boes
- Applicant: Michael C Boes
- Applicant Address: DE Martinsried
- Assignee: Affectis Pharmaceuticals AG
- Current Assignee: Affectis Pharmaceuticals AG
- Current Assignee Address: DE Martinsried
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: EP09005324 20090414; EP10156190 20100311
- Main IPC: A61K31/437
- IPC: A61K31/437 ; A61K31/404 ; C07D221/00 ; C07D209/00
Abstract:
The present application is directed to novel P2X7R antagonists that are N-indol-3-yl-acetamide and N-azaindol-3-yl-acetamide compounds, pharmaceutical compositions comprising the same and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity.
Public/Granted literature
- US20110212992A1 NOVEL P2X7R ANTAGONISTS AND THEIR USE Public/Granted day:2011-09-01
Information query
IPC分类:
